![](https://unicorn-nest.com/wp-content/uploads/avatars/funds/fund_public_square_partners.jpg?x55332)
Related Funds
Funds with similar focus
Fund Name | Location |
BR Capital | Cayman Islands, Midland |
BRED Banque | France, Ile-de-France, Paris |
C.E. Unterberg, Towbin | New York, New York, United States |
CareDx | Brisbane, California, United States |
CPG veterans | - |
Global Reserve Group | New York, Quaker Street, United States |
Hatch Blue Ltd | Cork, County Cork, Ireland |
Hebei Technology Investment Group | China, Hebei, Shijiazhuang |
HK Rothsfortune Investment Management | - |
India Today Group | India, Noida, Uttar Pradesh |
Pacific Eagle Asset Management | California, San Ramon, United States |
Pilot Group | Florida, Sarasota, United States |
Porsche Digital | Germany, Ludwigsburg, Mecklenburg-Vorpommern |
Qifu Capital Management | China, Guangdong, Shenzhen |
SINBON Electronics | Taipei, Taiwan |
Sowefund | France, Ile-de-France, Paris |
Washington H. Soul Pattinson | Australia, New South Wales, Sydney |
West End Holdings | Nashville, Tennessee, United States |
Wharton Capital | New York, New York, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
SPR Therapeutics | $5M | 08 Jan 2013 | Cleveland, Ohio, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
SPR Therapeutics | $5M | 08 Jan 2013 | Cleveland, Ohio, United States |